ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
ATOR-1017 (evunzekibart) 是一种 Fc-γ 受体条件性 4-1BB 激动剂,旨在实现最佳安全性和有效性,与抗 PD-1 联合使用可激活耗竭的 T 细胞
期刊:Cancer Immunology Immunotherapy
影响因子:8.1
doi:10.1007/s00262-023-03548-7
Karin Enell Smith #, Sara Fritzell #, Anneli Nilsson, Karin Barchan, Anna Rosén, Lena Schultz, Laura Varas, Anna Säll, Nadia Rose, Maria Håkansson, Laura von Schantz, Peter Ellmark
免疫
细胞生物学
T细胞
T Cell Receptor